Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.4B | 1.1B | 1.2B | 1.2B |
| Cost of revenue | 683M | 583M | 607M | 585M |
| Gross profit | 702M | 506M | 579M | 569M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 186M | 211M | 165M | 173M |
| Operating income | 452M | 237M | 358M | 341M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 48M | 54M | 50M | 52M |
| Other income expense | 23M | 92M | 9M | 57M |
| Pretax income | 427M | 275M | 317M | 346M |
| Tax provision | 93M | 64M | 78M | 87M |
| Net income | 334M | 211M | 239M | 259M |
| Basic EPS | 1.2 | 0.7 | 0.8 | 0.9 |
| Diluted EPS | 1.2 | 0.7 | 0.8 | 0.9 |
| Basic average shares | 14.6M | 14.6M | 14.5M | 14.5M |
| Diluted average shares | 14.7M | 14.6M | 14.6M | 14.6M |
| EBITDA | 516M | 296M | 415M | 398M |
| Net income from continuing op. | 334M | 211M | 238M | 260M |
| Minority interests | -3M | -1M | -5M | -2M |
| Preferred stock dividends | 4M | 3M | 3M | 3M |